tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

ADMP Stock Latest News

Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
Press ReleasesAdamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
15d ago
ADMP
Adamis Pharmaceuticals Announces Reverse Stock Split
Press ReleasesAdamis Pharmaceuticals Announces Reverse Stock Split
21d ago
ADMP
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Press ReleasesAdamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
25d ago
ADMP
Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
Press ReleasesAdamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
1M ago
ADMP
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Press ReleasesAdamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
3M ago
ADMP
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
Press ReleasesAdamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
3M ago
ADMP
Adamis Pharmaceuticals announces $3.0M registered direct offering
The FlyAdamis Pharmaceuticals announces $3.0M registered direct offering
3M ago
ADMP
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
Press ReleasesAdamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
3M ago
ADMP
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
Press ReleasesAdamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
3M ago
ADMP
Adamis Pharmaceuticals and DMK Pharmaceuticals announce merger, no terms
The FlyAdamis Pharmaceuticals and DMK Pharmaceuticals announce merger, no terms
3M ago
ADMP
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements
Press ReleasesNasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements
4M ago
ADMP
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesAdamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7M ago
ADMP
Adamis Announces Review of Strategic Alternatives
Press ReleasesAdamis Announces Review of Strategic Alternatives
8M ago
ADMP
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
Press ReleasesAdamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
9M ago
ADMP
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
Press ReleasesAdamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
9M ago
ADMP
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
Press ReleasesAdamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
10M ago
ADMP
Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesAdamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
10M ago
ADMP
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
Press ReleasesAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
10M ago
ADMP
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
Press ReleasesAdamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
11M ago
ADMP
Adamis Pharma Updates 1 Key Risk Factor
Market NewsAdamis Pharma Updates 1 Key Risk Factor
1y ago
ADMP